Mangoceuticals
MGRX
8 hedge funds and large institutions have $72K invested in Mangoceuticals in 2024 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 2 closing their positions.
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
106% more capital invested
Capital invested by funds: $34.9K → $72K (+$37.1K)
60% more funds holding
Funds holding: 5 → 8 (+3)
0.05% more ownership
Funds ownership: 0.05% → 0.1% (+0.05%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Mercer Global Advisors
Denver,
Colorado
|
+$26.5K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$24.4K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$6.46K |
| 4 |
MCG
McCollum Christoferson Group
Amherst,
New York
|
+$3.98K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$3.83K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$8K |
| 2 |
VCWA
Vanguard Capital Wealth Advisors
Denver,
Colorado
|
-$6.92K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $25.2K | +$24.4K | +6,140 | +413% |
|
|
2
Mercer Global Advisors
Denver,
Colorado
| $22K | +$26.5K | +6,667 | New |
|
|
MCG
3
McCollum Christoferson Group
Amherst,
New York
| $9.26K | +$3.98K | +1,000 | +54% |
|
|
XT
4
XTX Topco
George Town,
Cayman Islands
| $5.36K | +$6.46K | +1,623 | New |
|
|
FDCDDQ
5
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $4.77K | – | – | – |
|
|
6
UBS Group
Zurich,
Switzerland
| $3.13K | +$3.83K | +963 | New |
|
7
Morgan Stanley
New York
| $2.25K | +$2.75K | +691 | New |
|
|
BL
8
BFSG LLC
Irvine,
California
| $44 | +$52 | +13 | New |
|
|
9
Renaissance Technologies
New York
| – | -$8K | -2,031 | Closed |
|
|
VCWA
10
Vanguard Capital Wealth Advisors
Denver,
Colorado
| – | -$6.92K | -1,667 | Closed |
|
MGRX Hedge Fund Activity: Q1 2024 in Review
8 of the 6,946 institutional investors tracked by Wall St. Rank reported a position in Mangoceuticals (MGRX) for Q1 2024, worth a combined $72K — up 106% from $34.9K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new MGRX positions and 2 closed out — a net gain of 3 holders — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Mercer Global Advisors, opening a new position worth an estimated $26.5K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $8K sold.
- 8 institutional investors held Mangoceuticals (MGRX) as of Q1 2024, up from 5 in Q4 2023.
- Funds reported $72K of Mangoceuticals stock for Q1 2024, up 106% quarter-over-quarter.
- 5 funds opened new Mangoceuticals positions in Q1 2024 and 2 closed out, a net change of +3 holders.
- The largest Mangoceuticals buyer in Q1 2024 was Mercer Global Advisors, an estimated $26.5K added.
- The largest Mangoceuticals seller in Q1 2024 was Renaissance Technologies, an estimated $8K sold.
Based on aggregated 13F filings for Q1 2024.